Sign In
Buy LIVN
$80.14
-0.91 (-1.12%)
At Close: Jul 31, 2026
LivaNova (NASDAQ:LIVN) Upgraded to Buy by ValuEngine
07:54am, Saturday, 29'th Feb 2020
LivaNova (NASDAQ:LIVN) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Saturday, ValuEngine reports. Several other brokerag
Pune, Feb. 28, 2020 -- Vagus Nerve Stimulation (VNS) Market Overview The global vagus nerve stimulation (VNS) market size is anticipated to reach USD 1,194.4 million by.
NEW YORK, Feb. 27, 2020 -- The global medical bionics market was valued at USD 20.3 billion in 2019 and is expected to grow at a CAGR of 8.0% during the forecast period..
LivaNova (LIVN) Receives a Rating Update from a Top Analyst
11:43am, Thursday, 27'th Feb 2020
Canaccord Genuity analyst Jason Mills maintained a Hold rating on LivaNova (LIVN) today and set a price target of $66.00. The company's shares closed last
LivaNova (LIVN) Receives a Rating Update from a Top Analyst
11:43am, Thursday, 27'th Feb 2020
Canaccord Genuity analyst
Jason Mills
maintained a
Hold
rating on LivaNova (
LIVN
–
Research Report
) today and set a price target of
$66.00
. The company’s shares closed last Monday at $62.70, cl
LivaNova (LIVN) Gets a Buy Rating from Berenberg Bank
09:21am, Thursday, 27'th Feb 2020
Berenberg Bank analyst Scott Bardo maintained a Buy rating on LivaNova (LIVN) yesterday and set a price target of $114.00. The company's shares closed
LivaNova (LIVN) Gets a Buy Rating from Berenberg Bank
09:20am, Thursday, 27'th Feb 2020
Berenberg Bank analyst
Scott Bardo
maintained a
Buy
rating on LivaNova (
LIVN
–
Research Report
) yesterday and set a price target of
$114.00
. The company’s shares closed last Monday at $62.70, c
LivaNova PLC (LIVN) Q4 2019 Earnings Call Transcript
02:33am, Thursday, 27'th Feb 2020
LIVN earnings call for the period ending December 31, 2019.
Edited Transcript of LIVN.L earnings conference call or presentation 26-Feb-20 1:00pm GMT
09:45pm, Wednesday, 26'th Feb 2020
Q4 2019 LivaNova PLC Earnings Call
LivaNova Enters Research Collaboration with Verily to Gain New Insights into Vagus Nerve Stimulation Impact on Difficult-to-Treat Depression
09:44pm, Wednesday, 26'th Feb 2020
LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC announced a research collaboration with Verily, an Alphabet company, to capture measures of depression within its RECOVER clinical study.
LivaNova PLC (LIVN) CEO Damien McDonald on Q4 2019 Results - Earnings Call Transcript
06:17pm, Wednesday, 26'th Feb 2020
LivaNova PLC (NASDAQ:LIVN) Q4 2019 Earnings Conference Call February 26, 2020 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate
BRIEF-Livanova Reports Q4 Diluted EPS Loss From Continuing Ops $2.96 USD
12:34pm, Wednesday, 26'th Feb 2020
LivaNova PLC:
LivaNova (LIVN) Q4 Earnings Top Estimates
12:30pm, Wednesday, 26'th Feb 2020
LivaNova (LIVN) delivered earnings and revenue surprises of 5.26% and -1.54%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
LivaNova (LIVN) Q4 Earnings Top Estimates
12:30pm, Wednesday, 26'th Feb 2020
LivaNova (LIVN) delivered earnings and revenue surprises of 5.26% and -1.54%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
LivaNova Reports Fourth Quarter and Full-Year 2019 Results
11:00am, Wednesday, 26'th Feb 2020
LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC today reported results for the quarter and full-year ended December 31, 2019.
